Cargando…
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770921/ http://dx.doi.org/10.1053/j.gastro.2021.12.211 |
| _version_ | 1784635480362450944 |
|---|---|
| author | Cerna, Karin Duricova, Dana Lukas, Martin Machkova, Nadezda Hruba, Veronika Lukas, Milan |
| author_facet | Cerna, Karin Duricova, Dana Lukas, Martin Machkova, Nadezda Hruba, Veronika Lukas, Milan |
| author_sort | Cerna, Karin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8770921 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87709212022-01-20 ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS Cerna, Karin Duricova, Dana Lukas, Martin Machkova, Nadezda Hruba, Veronika Lukas, Milan Gastroenterology Uncontrolled Therapeutic Observations in Humans Using Biologic or Non-Biologic Agents Published by Elsevier Inc. 2022-02 2022-01-20 /pmc/articles/PMC8770921/ http://dx.doi.org/10.1053/j.gastro.2021.12.211 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Uncontrolled Therapeutic Observations in Humans Using Biologic or Non-Biologic Agents Cerna, Karin Duricova, Dana Lukas, Martin Machkova, Nadezda Hruba, Veronika Lukas, Milan ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title | ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title_full | ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title_fullStr | ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title_full_unstemmed | ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title_short | ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS |
| title_sort | anti-sars-cov-2 vaccination and antibody response in patients with inflammatory bowel disease on immune-modifying therapy. prospective single tertiary center study on 602 ibd patients |
| topic | Uncontrolled Therapeutic Observations in Humans Using Biologic or Non-Biologic Agents |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770921/ http://dx.doi.org/10.1053/j.gastro.2021.12.211 |
| work_keys_str_mv | AT cernakarin antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients AT duricovadana antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients AT lukasmartin antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients AT machkovanadezda antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients AT hrubaveronika antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients AT lukasmilan antisarscov2vaccinationandantibodyresponseinpatientswithinflammatoryboweldiseaseonimmunemodifyingtherapyprospectivesingletertiarycenterstudyon602ibdpatients |